Results
1 -
10 of
45Soucy Teresa A., Smith Peter G., Milhollen Michael A., Berger Allison J., Gavin James M., Adhikari Sharmila, Brownell James E., Burke Kristine E., Cardin David P., Critchley Stephen, Cullis Courtney A., Doucette Amanda, Garnsey James J., Gaulin Jeffrey L., Gershman Rachel E., Lublinsky Anna R., McDonald Alice, Mizutani Hirotake, Narayanan Usha, Olhava Edward J., Peluso Stephane, Rezaei Mansoureh, Sintchak Michael D., Talreja Tina, Thomas Michael P., Traore Tary, Vyskocil Stepan, Weatherhead Gabriel S., Yu Jie, Zhang Julie, Dick Lawrence R., Claiborne Christopher F., Rolfe Mark, Bolen Joseph B., Langston Steven P..
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer, Nature, 2009 Drugs with Diverse Modes of Action, Molecular Therapies of Cancer Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia, Impact of Genetic Targets on Cancer Therapy Novel agents in acute myeloid leukemia, International Journal of Hematology Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction, Macromolecular Protein Complexes Identification and Application of NEDD8 E1 Inhibitors, Ubiquitin Family Modifiers and the Proteasome Second-Generation Proteasome Inhibitors, Bortezomib in the Treatment of Multiple Myeloma Induction of P21-Dependent Senescence: Role of NAE Inhibitor MLN4924, Tumor Dormancy, Quiescence, and Senescence, Volume 2 The Ubiquitin-Proteasome System (UPS) as a Cancer Drug Target: Emerging Mechanisms and Therapeutics, Stress Response Pathways in Cancer Adenosine and gastrointestinal inflammation, Journal of Molecular Medicine